07:03 EDT Harvard Bioscience (HBIO) sees Q3 revenue $19M-$21M
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- HBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harvard Bioscience: Strong Q2 Performance and Strategic Leadership Changes Drive Buy Rating
- Harvard Bioscience Announces CEO Succession Plan
- Harvard Bioscience announces CEO succession plan, appointment of two directors
- Harvard Bioscience Faces Nasdaq Compliance Challenge